Marshall Wace, LLP Meridian Bioscience Inc Transaction History

Marshall Wace, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $1.44 Million - $1.54 Million	46,229 Added 43.21%	153,227 $5.09 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $655,605 - $711,830	-21,217 Reduced 16.55%	106,998 $3.37 Million
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $2.38 Million - $3.18 Million	100,253 Added 358.53%	128,215 $3.9 Million
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $558,401 - $753,296	27,962 New	27,962 $726,000
Q1 2021 May 17, 2021	SELL	$19.76 - $29.89 $2.5 Million - $3.78 Million	-126,430 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $589,607 - $811,881	37,483 Added 42.14%	126,430 $2.36 Million
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $1.2 Million - $2.35 Million	88,947 New	88,947 $1.51 Million
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $1.31 Million - $3.9 Million	-167,361 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $1.81 Million - $3.73 Million	-324,673 Reduced 65.99%	167,361 $1.41 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $828,196 - $1.06 Million	104,835 Added 27.08%	492,034 $4.81 Million
Q3 2019 Nov 14, 2019	BUY	$9.17 - $12.01 $681,450 - $892,499	74,313 Added 23.75%	387,199 $3.68 Million
Q2 2019 Aug 14, 2019	BUY	$10.88 - $17.6 $2.52 Million - $4.08 Million	231,721 Added 285.49%	312,886 $3.72 Million
Q1 2019 May 14, 2019	SELL	$15.51 - $17.61 $2.45 Million - $2.79 Million	-158,223 Reduced 66.09%	81,165 $1.43 Million
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $3.48 Million - $4.72 Million	239,388 New	239,388 $4.16 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.